# FDA Inspection 1072837 - Osteolife Biomedical I LLC - November 28, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/osteolife-biomedical-i-llc/32fed49c-542d-4511-bac7-6f630477eced
Source feed: FDA_Inspections

> FDA Inspection 1072837 for Osteolife Biomedical I LLC on November 28, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1072837
- Company Name: Osteolife Biomedical I LLC
- Inspection Date: 2018-11-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1302716 - 2026-02-13](https://www.globalkeysolutions.net/records/fda_inspections/osteolife-biomedical-i-llc/cc42555d-bb87-4991-9795-ca2e6e41f2c6)
- [FDA Inspection 1197358 - 2023-02-14](https://www.globalkeysolutions.net/records/fda_inspections/osteolife-biomedical-i-llc/bb9c9c01-6cf2-4c65-9707-d7c17b551837)
- [FDA Inspection 1197358 - 2023-02-14](https://www.globalkeysolutions.net/records/fda_inspections/osteolife-biomedical-i-llc/eef2a42a-0d42-4d5a-a386-6797bcbfc617)
- [FDA Inspection 1161595 - 2022-02-04](https://www.globalkeysolutions.net/records/fda_inspections/osteolife-biomedical-i-llc/6bfd2c91-c8f3-4587-9338-090c61ef0329)
- [FDA Inspection 1161595 - 2022-02-04](https://www.globalkeysolutions.net/records/fda_inspections/osteolife-biomedical-i-llc/5b7093ad-67ff-4efc-ae4a-d1ef678fd656)

Company: https://www.globalkeysolutions.net/companies/osteolife-biomedical-i-llc/65c313b4-28a5-4ecc-875c-ac366081fdc2

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d